test

Ilko Menkov

@Vestal Point Capital, Lp

Latest period2024 - Q3ReportedManaged Assets$1.319BTotal holdings69
Assets growth rate-1.67%Assets growth rate (2-Q avg)4.62%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Vestal Point Capital, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 69 positions.

Assets under management

The assets under management (AUM) of Vestal Point Capital, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.319B in assets, with a quarterly growth rate of -1.67% and a 2-quarter average growth rate of 4.62%. The portfolio is managed by Ilko Menkov, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
APLTApplied Therapeutics Inc
Recent Activity
Decreased -78.91%
0.74%
$9.732M
1.145M shares@ $8.5 avg price
NRIXNurix Therapeutics Inc
Recent Activity
Decreased -15%
0.73%
$9.55M
425,000 shares@ $22.47 avg price
FATEFate Therapeutics Inc
Recent Activity
Decreased -15.75%
0.45%
$5.897M
1.685M shares@ $3.5 avg price
ALLOAllogene Therapeutics Inc
Recent Activity
Decreased -31.81%
0.32%
$4.2M
1.5M shares@ $2.8 avg price
PTCTPtc Therapeutics Inc
Recent Activity
Decreased -11.11%
0.23%
$2.968M
80,000 shares@ $37.1 avg price
VYGRVoyager Therapeutics Inc
Recent Activity
Decreased -18.33%
0.22%
$2.866M
490,000 shares@ $5.85 avg price
RLMDRelmada Therapeutics Inc
Recent Activity
Decreased -59.16%
0.13%
$1.588M
490,000 shares@ $3.24 avg price